Abstract: A robot control system according to a present embodiment is a robot control system for controlling a mobile robot that is configured to autonomously within a facility. When it is detected that one or more used trays, among a plurality of trays used for meal service within the facility, are returned to a first prescribed place, the system instructs the mobile robot to collect the trays returned to the first prescribed place and deliver the trays to a second prescribed place.

Abstract: An autonomous movement system according to an embodiment is an autonomous movement system that performs autonomous movement in a facility including an elevator, in which the autonomous movement system moves a waiting position in a car of the elevator, based on a person that gets on the car or an object that gets on the car. The autonomous movement system may determine the person or the object before the car stops at a floor or before a car door opens.

Abstract: In a conveyance system, a conveyance object is conveyed by use of a plurality of mobile robots autonomously movable inside a facility. In a case where a blockade request event occurs in at least one area inside the facility, the conveyance system receives occurrence information transmitted from a facility management system configured to manage the facility and causes the mobile robots to execute an operation restriction to restrict operations of the mobile robots. In a case where a predetermined condition for the blockade request event is established after the mobile robots execute the operation restriction, the conveyance system reboots the mobile robots.

Abstract: An autonomous movement system according to an embodiment is an autonomous movement system for autonomous movement in a facility, the autonomous movement system changing a movement speed for the autonomous movement depending on a cooperation mode, a connection mode and a caution mode, the cooperation mode being a mode of moving while acquiring position information inside a first range in cooperation with a facility camera, the first range being a range that the facility camera photographs to generate image data, the facility camera being fixed in the facility, the connection mode being a mode of moving inside a second range and outside the first range, the second range being a range in which connection with an access point is performed by wireless communication, the access point being fixed in the facility, the caution mode being a mode of moving outside the first range and outside the second range.

Abstract: A rigid-flexible substrate includes a plurality of rigid portions, and a flexible portion connecting the plurality of rigid portions and including a portion of a first resin sheet including at least one layer of a thermoplastic resin sheet, the rigid portions including a portion of the first resin sheet other than the flexible portion, and a second resin sheet including a plurality of thermoplastic resin sheets laminated on one surface or both surfaces of the portion of the first resin sheet other than the flexible portion, and a tapered portion is provided at an end edge of the second resin sheet on a side close to the flexible portion, and a thickness of the tapered portion in a direction in which the second resin sheet is laminated decreases toward the flexible portion and is substantially 0 at a position in contact with the flexible portion.

Abstract: A rigid-flexible substrate includes a plurality of rigid portions, and a flexible portion connecting the plurality of rigid portions and including a portion of a first resin sheet including at least one layer of a thermoplastic resin sheet, the rigid portions including a portion of the first resin sheet other than the flexible portion, and a second resin sheet including a plurality of thermoplastic resin sheets laminated on one surface or both surfaces of the portion of the first resin sheet other than the flexible portion, and a tapered portion is provided at an end edge of the second resin sheet on a side close to the flexible portion, and a thickness of the tapered portion in a direction in which the second resin sheet is laminated decreases toward the flexible portion and is substantially 0 at a position in contact with the flexible portion.

Abstract: This invention provide to a pharmaceutical composition for treating spinocerebellar ataxia (or atrophy, degeneration) or multiple system atrophy, or for improving ataxia or equilibrium disturbance comprising a compound of the formula (I): wherein R is methyl, cyano or carbamoyl, a pharmaceutically acceptable salt, or a solvate thereof as an active ingredient.

Abstract: A multilayer circuit board includes a laminate having a plurality of ceramic layers, and a wiring pattern disposed in the laminate, wherein a ceramic layer includes, as the wiring pattern, a fully penetrating via-hole conductor that vertically passes through the ceramic layers, and a serial partially penetrating via-hole conductor that is electrically connected to the fully penetrating via-hole conductor in the ceramic layers and does not pass completely through the ceramic layers.

Abstract: A multilayer circuit board includes a laminate having a plurality of ceramic layers, and a wiring pattern disposed in the laminate, wherein a ceramic layer includes, as the wiring pattern, a fully penetrating via-hole conductor that vertically passes through the ceramic layers, and a serial partially penetrating via-hole conductor that is electrically connected to the fully penetrating via-hole conductor in the ceramic layers and does not pass completely through the ceramic layers.

Abstract: This invention provide to a pharmaceutical composition for treating spinocerebellar ataxia (or atrophy, degeneration) or multiple system atrophy, or for improving ataxia or equilibrium disturbance comprising a compound of the formula (I): wherein R is methyl, cyano or carbamoyl, a pharmaceutically acceptable salt, or a solvate thereof as an active ingredient.

Abstract: The present invention provides a percutaneously administrable preparation comprising either an aqueous base comprising 1-menthol, a lower alcohol and an acidic buffer or water, or an oily base comprising 1-menthol, a lower alcohol and isopropyl myristate, and a cerebral function activator, for example, 2-(3-isoxazolyl)-3,6,7,9-tetrahydroimidazo[4,5-d]pyrano[4,3-b]pyridine, pharmaceutically acceptable salt or hydrate thereof.

Abstract: The present invention provides enteric coated preparation excellent in absorbability, containing thyrotropin-releasing hormone (TRH) or derivatives thereof as a medicinally active ingredient.

Abstract: The present invention provides an oil preparation comprising a high lipophilic medicament such as a compound of the formula (I): 1

Abstract: A peptide derivation of the formula (I) or its pharmaceutically acceptable salt or hydrate thereof is disclosed. These compounds have superior ability over thyroid stimulating hormone (TRH) and its derivatives to activate the central nervous system, such as, for example, sustained acetylcholine releasing action, anti-reserpine action and locomotor increment.